Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
49,633,071
-
Total 13F shares
-
30,174,656
-
Share change
-
-2,551,001
-
Total reported value
-
$91,838,926
-
Put/Call ratio
-
50%
-
Price per share
-
$3.04
-
Number of holders
-
94
-
Value change
-
-$38,933,125
-
Number of buys
-
53
-
Number of sells
-
66
Institutional Holders of PUMA BIOTECHNOLOGY, INC. - Common Stock (PBYI) as of Q4 2021
As of 31 Dec 2021 PUMA BIOTECHNOLOGY, INC. - Common Stock (PBYI) had 94 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 30,174,656 shares of stock of the company.
Largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., GOLDMAN SACHS GROUP INC, Camber Capital Management LP, RENAISSANCE TECHNOLOGIES LLC, ACADIAN ASSET MANAGEMENT LLC, MILLENNIUM MANAGEMENT LLC, Eversept Partners, LP, JACOBS LEVY EQUITY MANAGEMENT, INC, and D. E. Shaw & Co., Inc..
This table shows 94 institutional shareholders of the security as of 31 Dec 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.